DK3273957T3 - Biotin til behandling af demyeliniserende neuropatier - Google Patents
Biotin til behandling af demyeliniserende neuropatier Download PDFInfo
- Publication number
- DK3273957T3 DK3273957T3 DK16713833T DK16713833T DK3273957T3 DK 3273957 T3 DK3273957 T3 DK 3273957T3 DK 16713833 T DK16713833 T DK 16713833T DK 16713833 T DK16713833 T DK 16713833T DK 3273957 T3 DK3273957 T3 DK 3273957T3
- Authority
- DK
- Denmark
- Prior art keywords
- demyelinizing
- neuropathy
- biotin
- treat
- treat demyelinizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Magnetic Ceramics (AREA)
- Manufacture, Treatment Of Glass Fibers (AREA)
- Farming Of Fish And Shellfish (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15305437.4A EP3072513A1 (en) | 2015-03-26 | 2015-03-26 | Biotin for treating Amyotrophic lateral sclerosis |
PCT/EP2016/056696 WO2016151132A1 (en) | 2015-03-26 | 2016-03-25 | Biotin for treating amyotrophic lateral sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3273957T3 true DK3273957T3 (da) | 2019-11-11 |
Family
ID=52779582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16713833T DK3273957T3 (da) | 2015-03-26 | 2016-03-25 | Biotin til behandling af demyeliniserende neuropatier |
Country Status (23)
Country | Link |
---|---|
US (2) | US10357480B2 (da) |
EP (2) | EP3072513A1 (da) |
JP (1) | JP6752874B2 (da) |
KR (1) | KR20170131543A (da) |
CN (2) | CN107405335A (da) |
AU (1) | AU2016238759B2 (da) |
BR (1) | BR112017020408A2 (da) |
CA (1) | CA2980660A1 (da) |
CY (1) | CY1122374T1 (da) |
DK (1) | DK3273957T3 (da) |
EA (1) | EA034394B1 (da) |
ES (1) | ES2748354T3 (da) |
HR (1) | HRP20191491T1 (da) |
HU (1) | HUE046116T2 (da) |
IL (1) | IL254619B (da) |
LT (1) | LT3273957T (da) |
MA (1) | MA41809B1 (da) |
ME (1) | ME03567B (da) |
PL (1) | PL3273957T3 (da) |
PT (1) | PT3273957T (da) |
RS (1) | RS59149B1 (da) |
SI (1) | SI3273957T1 (da) |
WO (1) | WO2016151132A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
EP3275439A1 (en) | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
CN112386703A (zh) * | 2020-01-15 | 2021-02-23 | 李启芳 | 治疗als的联合用药物及其应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885976A (en) * | 1995-05-08 | 1999-03-23 | Sandyk; Reuven | Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions |
MXPA05003243A (es) | 2002-09-27 | 2005-09-12 | Biogen Idec Inc | Terapias para polineuropatia desmielinizante inflamatoria cronica usando interferon-beta. |
US20050249823A1 (en) * | 2003-11-04 | 2005-11-10 | Murphy Tanya K | Methods for the prevention or amelioration of neuropsychiatric and related diseases |
US7105183B2 (en) * | 2004-02-03 | 2006-09-12 | The Regents Of The University Of California | Chlorite in the treatment of neurodegenerative disease |
FR2905868B1 (fr) * | 2006-09-18 | 2012-12-21 | Gemac | Composition destinee au traitement de la sclerose laterale amyotrophique |
BR112012015084A2 (pt) | 2009-12-23 | 2017-03-07 | Lupin Ltd | composição farmacêutica de liberação lenta de iloperidone |
FR2958166B1 (fr) | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
FR2993780B1 (fr) * | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
EP2699256B1 (en) * | 2011-04-21 | 2017-09-27 | The Regents of the University of Colorado, a body corporate | Compositions and methods for the treatment of neuromyelitis optica |
EP2731611B1 (en) * | 2011-07-13 | 2019-09-18 | Cytokinetics, Inc. | Combination therapie for als |
WO2014177286A1 (en) | 2013-04-29 | 2014-11-06 | Assistance Publique - Hopitaux De Paris | Biotin for use in treating x-linked adrenoleukodystrophy |
JP6664956B2 (ja) * | 2015-02-27 | 2020-03-13 | キリンホールディングス株式会社 | 筋分化促進組成物 |
EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
-
2015
- 2015-03-26 EP EP15305437.4A patent/EP3072513A1/en not_active Ceased
-
2016
- 2016-03-25 HU HUE16713833A patent/HUE046116T2/hu unknown
- 2016-03-25 BR BR112017020408A patent/BR112017020408A2/pt not_active Application Discontinuation
- 2016-03-25 CN CN201680018463.8A patent/CN107405335A/zh active Pending
- 2016-03-25 EP EP16713833.8A patent/EP3273957B1/en active Active
- 2016-03-25 AU AU2016238759A patent/AU2016238759B2/en not_active Ceased
- 2016-03-25 LT LT16713833T patent/LT3273957T/lt unknown
- 2016-03-25 CA CA2980660A patent/CA2980660A1/en not_active Abandoned
- 2016-03-25 ME MEP-2019-285A patent/ME03567B/me unknown
- 2016-03-25 PL PL16713833T patent/PL3273957T3/pl unknown
- 2016-03-25 US US15/561,911 patent/US10357480B2/en not_active Expired - Fee Related
- 2016-03-25 ES ES16713833T patent/ES2748354T3/es active Active
- 2016-03-25 MA MA41809A patent/MA41809B1/fr unknown
- 2016-03-25 WO PCT/EP2016/056696 patent/WO2016151132A1/en active Application Filing
- 2016-03-25 EA EA201792124A patent/EA034394B1/ru not_active IP Right Cessation
- 2016-03-25 DK DK16713833T patent/DK3273957T3/da active
- 2016-03-25 CN CN202010704334.2A patent/CN111973592A/zh active Pending
- 2016-03-25 RS RS20191089A patent/RS59149B1/sr unknown
- 2016-03-25 SI SI201630372T patent/SI3273957T1/sl unknown
- 2016-03-25 JP JP2018500860A patent/JP6752874B2/ja not_active Expired - Fee Related
- 2016-03-25 KR KR1020177030427A patent/KR20170131543A/ko unknown
- 2016-03-25 PT PT16713833T patent/PT3273957T/pt unknown
-
2017
- 2017-09-24 IL IL254619A patent/IL254619B/en active IP Right Grant
-
2019
- 2019-06-25 US US16/451,654 patent/US20190314342A1/en not_active Abandoned
- 2019-08-19 HR HRP20191491 patent/HRP20191491T1/hr unknown
- 2019-11-13 CY CY20191101195T patent/CY1122374T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL3273957T3 (pl) | 2020-01-31 |
BR112017020408A2 (pt) | 2018-06-05 |
HRP20191491T1 (hr) | 2019-11-15 |
IL254619B (en) | 2020-03-31 |
AU2016238759A1 (en) | 2017-10-05 |
CY1122374T1 (el) | 2021-01-27 |
US10357480B2 (en) | 2019-07-23 |
EP3273957B1 (en) | 2019-08-14 |
AU2016238759B2 (en) | 2020-08-06 |
EP3273957A1 (en) | 2018-01-31 |
MA41809B1 (fr) | 2019-12-31 |
US20190314342A1 (en) | 2019-10-17 |
IL254619A0 (en) | 2017-11-30 |
EA201792124A1 (ru) | 2018-04-30 |
EP3072513A1 (en) | 2016-09-28 |
JP2018512451A (ja) | 2018-05-17 |
KR20170131543A (ko) | 2017-11-29 |
RS59149B1 (sr) | 2019-09-30 |
SI3273957T1 (sl) | 2019-11-29 |
WO2016151132A1 (en) | 2016-09-29 |
CA2980660A1 (en) | 2016-09-29 |
JP6752874B2 (ja) | 2020-09-09 |
HUE046116T2 (hu) | 2020-02-28 |
ME03567B (me) | 2020-07-20 |
MA41809A (fr) | 2018-01-30 |
NZ735528A (en) | 2021-09-24 |
LT3273957T (lt) | 2019-11-11 |
US20180125825A1 (en) | 2018-05-10 |
ES2748354T3 (es) | 2020-03-16 |
EA034394B1 (ru) | 2020-02-04 |
PT3273957T (pt) | 2019-09-18 |
CN107405335A (zh) | 2017-11-28 |
CN111973592A (zh) | 2020-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3430141T3 (da) | Oligonukleotider til reduktion af PD-L1-ekspression | |
DK3283625T3 (da) | Nukleasemedieret genomeditering | |
DK3331869T3 (da) | Muscarinagonister | |
DK3305788T3 (da) | Janus-kinase-hæmmer | |
DK3277719T3 (da) | Polypeptider | |
DK3331528T3 (da) | Muskarinagonister | |
DK3360890T3 (da) | Genterapi | |
DK3331529T3 (da) | Muskarinagonister | |
DK3310450T3 (da) | Olie-vand-separator | |
DK3341479T3 (da) | LNA-G-Proces | |
DK3270930T3 (da) | Præeklampsi | |
DK3296597T3 (da) | Krydshovedmotor | |
DK3292136T3 (da) | Penicillin-g-acylaser | |
DK3283097T3 (da) | Fsh til behandling af infertilitet | |
DE112015006486A5 (de) | Inkubationsrinne | |
NO2023044I1 (no) | capromorelin | |
DK3274482T3 (da) | Stenborsknop | |
DK3318308T3 (da) | Badmintonketsjer | |
UY4467S (es) | Frasco | |
FR3033461B1 (fr) | Tuile photovoltaique | |
DK3273957T3 (da) | Biotin til behandling af demyeliniserende neuropatier | |
DE112016005599A5 (de) | Strahlungsgrill | |
DE112015005898A5 (de) | Gurtschlossbringer | |
DE102015206660A8 (de) | Plattenaufteilanlage | |
DE112016001124A5 (de) | Spannschutz |